These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9917519)

  • 1. The involvement of proteasome in myogenic differentiation of murine myocytes and human rhabdomyosarcoma cells.
    Mugita N; Honda Y; Nakamura H; Fujiwara T; Tanaka K; Omura S; Shimbara N; Ogawa M; Saya H; Nakao M
    Int J Mol Med; 1999 Feb; 3(2):127-37. PubMed ID: 9917519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells.
    Kudo Y; Takata T; Ogawa I; Kaneda T; Sato S; Takekoshi T; Zhao M; Miyauchi M; Nikai H
    Clin Cancer Res; 2000 Mar; 6(3):916-23. PubMed ID: 10741716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome-dependent regulation of p21WAF1/CIP1 expression.
    Blagosklonny MV; Wu GS; Omura S; el-Deiry WS
    Biochem Biophys Res Commun; 1996 Oct; 227(2):564-9. PubMed ID: 8878553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
    Liu LN; Dias P; Houghton PJ
    Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.
    Cory AH; Cory JG
    Anticancer Res; 2002; 22(6C):3805-9. PubMed ID: 12552998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors.
    Chen F; Chang D; Goh M; Klibanov SA; Ljungman M
    Cell Growth Differ; 2000 May; 11(5):239-46. PubMed ID: 10845424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early mitochondrial hyperpolarization and intracellular alkalinization in lactacystin-induced apoptosis of retinal pigment epithelial cells.
    Kim JM; Bae HR; Park BS; Lee JM; Ahn HB; Rho JH; Yoo KW; Park WC; Rho SH; Yoon HS; Yoo YH
    J Pharmacol Exp Ther; 2003 May; 305(2):474-81. PubMed ID: 12606642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactacystin increases LDL receptor level on HepG2 cells.
    Miura H; Tomoda H; Miura K; Takishima K; Omura S
    Biochem Biophys Res Commun; 1996 Oct; 227(3):684-7. PubMed ID: 8885994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis of Ewing's sarcoma cells is accompanied by accumulation of ubiquitinated proteins.
    Soldatenkov VA; Dritschilo A
    Cancer Res; 1997 Sep; 57(18):3881-5. PubMed ID: 9307264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p18INK4c and p27KIP1 are required for cell cycle arrest of differentiated myotubes.
    Myers TK; Andreuzza SE; Franklin DS
    Exp Cell Res; 2004 Nov; 300(2):365-78. PubMed ID: 15475001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.
    Cerundolo V; Benham A; Braud V; Mukherjee S; Gould K; Macino B; Neefjes J; Townsend A
    Eur J Immunol; 1997 Jan; 27(1):336-41. PubMed ID: 9022037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells.
    Pasquini LA; Besio Moreno M; Adamo AM; Pasquini JM; Soto EF
    J Neurosci Res; 2000 Mar; 59(5):601-11. PubMed ID: 10686588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibition leads to significant reduction of Bcr-Abl expression and subsequent induction of apoptosis in K562 human chronic myelogenous leukemia cells.
    Dou QP; McGuire TF; Peng Y; An B
    J Pharmacol Exp Ther; 1999 May; 289(2):781-90. PubMed ID: 10215653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tannic acid potently inhibits tumor cell proteasome activity, increases p27 and Bax expression, and induces G1 arrest and apoptosis.
    Nam S; Smith DM; Dou QP
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1083-8. PubMed ID: 11588135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proteasome is involved in angiogenesis.
    Oikawa T; Sasaki T; Nakamura M; Shimamura M; Tanahashi N; Omura S; Tanaka K
    Biochem Biophys Res Commun; 1998 May; 246(1):243-8. PubMed ID: 9600100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of the proteasome block the myogenic differentiation of rat L6 myoblasts.
    Kim SS; Rhee S; Lee KH; Kim JH; Kim HS; Kang MS; Chung CH
    FEBS Lett; 1998 Aug; 433(1-2):47-50. PubMed ID: 9738931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
    Ling YH; Liebes L; Jiang JD; Holland JF; Elliott PJ; Adams J; Muggia FM; Perez-Soler R
    Clin Cancer Res; 2003 Mar; 9(3):1145-54. PubMed ID: 12631620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation.
    Borriello A; Pietra VD; Criscuolo M; Oliva A; Tonini GP; Iolascon A; Zappia V; Ragione FD
    Oncogene; 2000 Jan; 19(1):51-60. PubMed ID: 10644979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of caspase-3 subunits from degradation contributes to apoptosis evoked by lactacystin: any single lysine or lysine pair of the small subunit is sufficient for ubiquitination.
    Chen L; Smith L; Wang Z; Smith JB
    Mol Pharmacol; 2003 Aug; 64(2):334-45. PubMed ID: 12869638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.